Sperm Bank Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Sperm Bank Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Sperm Bank market is expected to record a CAGR of 3.3% over the forecast period (2022 - 2027).

The outbreak of COVID-19 showed an impact on the sperm bank market. COVID-19 not only affected the sperm bank market but the entire healthcare industry. It has disrupted the supply chain, leaving a financial burden on many companies. Due to this pandemic, there were nationwide lockdowns in almost every country which restricted people to come to sperm banks, hospitals, etc for sperm donation or collection due to safety issues. For instance, according to an article published by Springer, in January 2022, titled "Safety issues in semen banks during the COVID-19 pandemic: data from a European survey", it has been observed that the majority of the centers didn't adopt any especially extreme safety precautions to reduce the possibility of viral contamination or transmission. Additionally, as per the same source, in the case of positive nasopharyngeal swab (NPS) patients, only 4/22 laboratories stored the sample in a dedicated tank. Also, different countries have different rules for semen collection and storage. For instance, Italian gamete cryopreservation regulation has established that it is necessary to have dedicated cryogenic containers for each of the different screened pathologies to avoid virus contamination. Thus, the lack of safety during the initial time of the pandemic has negatively impacted the market growth. However, releasing COVID-19 restriction and several measures taken by the sperm banks and centers to avoid contamination is expected to drive the market growth over the forecast period.

Certain factors that are propelling the market growth are growing acceptance of the LGBT community, increasing prevalence of poor fertility, and advancement in cryopreservation. For instance, according to an article published by StatPearls, in July 2022, titled "Male Infertility", it has been found that infertility affects 15% of all couples in the United States and at least 180 million worldwide. In addition, the estimated male infertility rate is 9% in Australia and 8% to 12% in Eastern Europe. Thus, the high prevalence of infertility among men population across the globe is expected to increase the demand for another invitro process by using other human semen is expected to increase the market growth over the forecast period.

Also, according to an article published by StatPearls, in July 2022, titled "Male Infertility", a single-blinded study conducted in 2020, showed a proprietary daily antioxidant blend of coenzyme Q10 (30 mg), zinc (8 mg), vitamins C (100 mg), and E (12 mg), folic acid (400 micrograms), and selenium (200 mcg every other day) were taken for three months by 50 idiopathic infertile men with abnormal semen analyses (oligozoospermia and asthenozoospermia), resulted in statistically significant improvements in sperm count, concentration, motility, morphology as well as better semen volume and pH.

In addition, the rising prevalence of obesity is also a risk factor causing low sperm count in men and infertility or low chances of getting pregnant in females. For instance, according to 2022 statistics published by World Obesity Federation, it has been observed that 31.5% of men and 40.2% of women are living with obesity in Mexico in 2020. Similarly, according to statistics published by Code Blue.org, in November 2021, it has been observed that the prevalence of overweight and obesity in the Malaysian adult population increased to 54.2% in 2020 as compared to 50.1% in 2019.

Furthermore, the rising advancements in semen cryopreservation to preserve sperm cells are also contributing to the growth of the studied market. For instance, in January 2021, a report published on serum-free cryopreservation by Merck, ThermoFisher, and Zenoaq stated that using the cryopreservation technique the sperm can be preserved without blood products which reduces the risk of cross-species virus infections.

However, the lack of awareness among people and the low availability of sperm banks are likely to restrain the market growth over the forecast period.

Key Market TrendsSemen Analysis Segment is Expected to Hold a Major Share Over the Forecast Period

The Semen Analysis segment is expected to witness significant growth over the forecast period owing to the factors such as increasing infertility in men due to various reasons such as changing lifestyles, underlying conditions, and others, increasing government initiatives as well as rising company activities.

The increasing company's focus on developing and launching testing kits for analyzing sperm quality is expected to increase the demand for semen analysis, thereby boosting the market growth. For instance, in October 2021, Inherent Biosciences launched Path Fertility's Epigenetic Sperm Quality Test, SpermQT, at the American Society for Reproductive Medicine Scientific Congress & Expo. SpermQT examines DNA methylation patterns on genes involved in sperm maturation, sperm production, and embryonic development. Additionally, in June 2021, Janani launched a first-of-its-kind at-home semen testing kit. The company has also developed a unique media that can store a sample without any damage to the sperms for up to 8 hours in non-laboratory conditions.

In addition, according to an article published by the Facts, Views, and Vision, Issues in Obstetrics, Gynecology and Reproductive Health in March 2021, titled "Simplified sperm testing devices: a possible tool to overcome lack of accessibility and inconsistency in male factor infertility diagnosis. An opportunity for low- and middle- income countries", it has been found that YO, SEEM, and ExSeed, a smartphone-based device, accurately measures volume, sperm concentration (millions/ml) and total motile sperm count. In addition, as per the same source, these technologies could efficiently choose patients for first-line artificial reproduction treatments such as intrauterine insemination due to their affordability, availability, accuracy, and ease of use. Thus, the rising utilization of such devices in examining and accessing sperm quality is likely to increase the demand for sperm analysis, thereby boosting the segment growth.

Furthermore, the rising government initiatives in introducing updated manual to ensure high-quality testing of human semen in the clinical and research setting is also contributing to the growth of the studied segment, thereby propelling the market growth. For instance, in August 2021, the World Health Organization launched the sixth laboratory manual for the examination and processing of human semen. The manual includes new and expanded sections on semen sample preparation, markers for infection, computer-aided sperm analysis, and detailed procedures for basic, extended and advanced examination of human semen.

Therefore, the due to aforementioned factors the studied market is expected to increase over the forecast period.

North America is Expected to Retain its Dominance in the Market

North America holds the largest market share in the sperm bank market and is expected to dominate the market over the forecast period.

The factors propelling the market growth are the rising number of male fertility due to increased levels of smoking, consumption of alcohol, use of certain illicit drugs, and underlying conditions such as obesity. For instance, according to an article published by StatPearls, in July 2022, titled "Male Infertility", it has been found that the estimated male infertility rate is between 4.5% to 6% in North America. Additionally, according to the World Health Organization, in 2021, 12% of the people in Canada smoke regularly. In addition, as per the same source, people aged 20 years or above have the highest rate of smoking (11%) as compared to people aged 15 years to 19 years (4%). The increasing level of smoking is linked to a high amount of ferroptosis in seminal plasma that impacts the quality of semen and reduces the chances of getting pregnant which are expected to propel the growth of the studied market over the forecast period.

Furthermore, as per the 2022 statistics published by the National Center for Drug Abuse Statistics, 10.2% of people aged 12 years and above have Alcohol Use Disorder, in 2020, in the United States. Also, the data published by the National Institute on Alcohol Abuse and Alcoholism, updated in March 2022, has found that 25.8% of the people aged 18 years and above were reported to have binge drinking habits in 2019.

Moreover, advancements in technology about cryopreservation and increasing company activities are also contributing to the growth of the market over the forecast period. For instance, in February 2021, Generate Life Sciences announced its expansion in Canada, with the introduction of California Cryobank. Also, in February 2020, Legacy, a male fertility startup, raised USD 3.5 million n funding from Bill Maris’s San Diego-based venture firm, Section 32, along with Y Combinator and Bain Capital Ventures.

Therefore, the due to aforementioned factors the studied market is expected to increase over the forecast period.

Competitive Landscape

The sperm bank market is highly competitive, with many key players dominating the market. The presence of major market players, such as CALIFORNIA CRYOBANK, Fairfax Cryobank, London Sperm Bank, Androcryos, Indian Spermtech, and European Sperm Bank, and Xytex Corporation, among few others, is intensifying the competition. Market players are adopting strategies, such as rising research and investments, mergers, acquisitions, and product innovations, in order to sustain the increasing market rivalry.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.